Status:
COMPLETED
Transdiagnostic Treatment for Emotional Disorders
Lead Sponsor:
Mohamad hasan yousefi
Conditions:
Depressive Symptoms
Anxiety
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Background and study aims Depression is more prevalent in younger populations. The age of first onset of depression has become younger, yet many adolescents with depressive symptoms remain untreated. ...
Detailed Description
Condition Depressive symptoms, anxiety symptom, emotional problems Interventions Participants in experimental group Receive 12 weeks training according to the guideline below Participants in control R...
Eligibility Criteria
Inclusion
- 18 years or older
- Ability to understand and read Persian or Pashto
- Access to Internet at home and having an email address
- Meeting the DSM-IV diagnostic criteria for ED (MDD, DD, MDNOS, PD, A, SAD, GAD, ADNOS, OCD)
Exclusion
- Suffering from a severe mental disorder (schizophrenia, bipolar disorder, and alcohol and/or substance dependence disorder)
- The presence of a high risk of suicide
- other chronic or Medical disease/condition that prevents the participant
- receiving another psychological treatment during the last six month
Key Trial Info
Start Date :
August 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2021
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT04498949
Start Date
August 15 2020
End Date
January 31 2021
Last Update
March 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Internet
Bāmyān, Afghanistan